教育研究推進系

Keyphrases

1. 3T3-L1 Adipocytes 18%
2. Amines 18%
3. Annulenes 50%
4. At-risk Mental State 54%
5. Atrial Fibrillation 35%
6. Benzyl 18%
7. Bidentate 21%
8. Bone Marrow Cells 16%
9. Cataplexy 17%
10. Chelates 26%
11. Circadian Clock 23%
12. Circadian Rhythm 22%
13. Circulating Tumor Cells 24%
14. Clinical Features 17%
15. Clinical High Risk for Psychosis (CHR-P) 23%
16. Cluster of Differentiation 44 (CD44) 16%
17. Code Trellis 16%
18. Cognitive Function 20%
19. Collider 22%
20. Colon 24%
21. Convolutional Codes 34%
22. Dark Matter 19%
23. Degranulation 18%
24. Deprotonated 17%
25. Dimethyl 20%
26. Disubstituted 17%
27. Dithiocarbazate 28%
28. Esophageal Cancer 26%
29. Esophageal Squamous Cell Carcinoma 64%
30. Fibroblasts 25%
31. First-episode Psychosis 23%
32. Food Allergy 45%
33. Gastric Cancer 16%
34. Gene Expression 17%
35. Glucose Transporter 4 (GLUT4) 21%
36. Guinea pig 16%
37. Healthy Controls 17%
38. Histamine 32%
39. Histamine Release 39%
40. Hydride Abstraction 16%
41. Hydrogen Bonds (H-bonds) 17%
42. Hypothalamus 32%
43. IgG4-positive Plasma Cell 18%
44. IgG4-related Disease (IgG4-RD) 100%
45. Immunoreactivity 17%
46. Inhibitory Effect 22%
47. Inositol Phosphatase 16%
48. Insulin 54%
49. Insulin Receptor 41%
50. Insulin Resistance 26%
51. Insulin Signaling 19%
52. Japan 23%
53. Knock-in Mouse Model 26%
54. Lung Cancer 23%
55. Mast Cells 39%
56. Methyl 21%
57. Microdialysis 28%
58. MicroRNA 17%
59. Mitogen-activated Protein Kinase 21%
60. Mitogenesis 16%
61. Mouse Model 23%
62. MRNA Expression 16%
63. Mucosal Mast Cells 26%
64. Network Biomarker 23%
65. Neutralino 16%
66. Nickel(II) 21%
67. Nighttime 30%
68. Non-small Cell Lung Cancer (NSCLC) 25%
69. Non-valvular Atrial Fibrillation 21%
70. Obesity 18%
71. Older Men 16%
72. Orexin 39%
73. Overexpressing 16%
74. P75 Neurotrophin Receptor (p75NTR) 27%
75. Patients with Schizophrenia 17%
76. Phosphoinositide 3-kinase (PI3K) 23%
77. Phosphorylation 26%
78. Pre-disease State 16%
79. Prognostic Significance 16%
80. Psychosis 32%
81. Raman Spectra 19%
82. Raman Spectroscopy 43%
83. Rapid Eye Movement Sleep 25%
84. REM Sleep 24%
85. Road Surface Condition 47%
86. Schiff Base 25%
87. Schizophrenia 54%
88. Schizophrenic Patients 20%
89. Shikonin 16%
90. Spectroscopic Techniques 16%
91. Suprachiasmatic nucleus 61%
92. Traditional Japanese Medicine 21%
93. Tram 16%
94. Transesophageal Echocardiography 28%
95. Trellis 36%
96. Tumor 44%
97. Tumor Necrosis Factor-α 17%
98. Type 2 Diabetes Mellitus (T2DM) 19%
99. Wakefulness 27%
100. Wild Mice 16%

Medicine and Dentistry

1. Abdominal Cancer 19%
2. Adipocyte 7%
3. Adipose Tissue 10%
4. Anticarcinogen 12%
5. Aortic Atherosclerosis 8%
6. Apoplexy 8%
7. At Risk Mental State 9%
8. Atrial Fibrillation 43%
9. Autoimmune Pancreatitis 9%
10. Biological Marker 10%
11. Bone Marrow Derived Mast Cell 10%
12. Bronchiolitis 7%
13. Cancer Cell 19%
14. Cancer Stem Cell 18%
15. Carcinogenesis 9%
16. Cell Line 10%
17. Cell Marker 15%
18. Cellular Infiltration 8%
19. CHADS2 Score 8%
20. Chemotherapy 14%
21. Circulating Tumor Cell 16%
22. Colon 17%
23. Colorectal Tumor 10%
24. Computer Assisted Tomography 9%
25. Degranulation 7%
26. Diabetes 12%
27. Diabetes Mellitus 8%
28. Diagnosis 21%
29. Discriminant Analysis 7%
30. Disease 49%
31. Disease Course 10%
32. Drug Therapy 10%
33. Dyspnea 7%
34. Elderly Patient 7%
35. Endoscopy 10%
36. Epithelial Cell 19%
37. Epithelial Cell Adhesion Molecule 12%
38. Esophageal Cancer 29%
39. Esophageal Squamous Cell Carcinoma 60%
40. Esophagectomy 35%
41. Esophagus 19%
42. Fibrosis 9%
43. Fluorine-18 7%
44. Fluorodeoxyglucose 7%
45. Food Allergy 13%
46. Gemcitabine 8%
47. Glucocorticoid 9%
48. Glucose Transporter 1 8%
49. Glucose Transporter 3 10%
50. Glucose Transporter 4 14%
51. Hemostat 11%
52. Histamine 8%
53. Idiopathic Interstitial Pneumonia 8%
54. IgG4-Related Disease 41%
55. Immune Checkpoint Inhibitor 12%
56. Immunoglobulin E 10%
57. Immunoglobulin G4 71%
58. Immunoglobulin G4 Related Disease 9%
59. Immunoglobulin Producing Cell 16%
60. In Vitro 24%
61. Indocyanine Green 8%
62. Jejunum 8%
63. Kampo 12%
64. Lung 23%
65. Lung Cancer 23%
66. Lung Lesion 13%
67. Lymph Node Metastasis 7%
68. Malignant Neoplasm 11%
69. Mast Cell 27%
70. Maturity Onset Diabetes of the Young 8%
71. Medicine 8%
72. Messenger RNA 15%
73. Metastatic Carcinoma 14%
74. microRNA 18%
75. Mikulicz Disease 9%
76. Multivariate Analysis 8%
77. Neoplasm 53%
78. Nephropathy 7%
79. Neurotrophin Receptor P75 24%
80. Non Small Cell Lung Cancer 15%
81. Odds Ratio 7%
82. Pancreas Cancer 17%
83. Peripheral Blood Mononuclear Cell 7%
84. Physical Activity Level 7%
85. Prognostic Factor 10%
86. Progression Free Survival 7%
87. Raman Spectrometry 31%
88. Receptor Expression 10%
89. Recurrent Disease 10%
90. Retrospective Study 8%
91. Silo-Filler's Disease 16%
92. Sinus Rhythm 10%
93. Small Cell Lung Cancer 11%
94. Stem Cell 11%
95. Surgery 14%
96. Surgical Anastomosis 8%
97. Thromboembolism 16%
98. Transesophageal Echocardiography 17%
99. Upregulation 9%
100. Vascularity 7%